You are here

Home » Content

Adana'da Lise Öğrencilerinde Hepatit B Farkındalık Düzeyi

HEPATITIS B AWARENESS AMONG HIGH SCHOOL STUDENTS IN ADANA

Journal Name:

  • Türkiye Aile Hekimliği Dergisi

Publication Year:

  • 2006

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Objective: Hepatitis B virus (HBV) is a common cause of liver disease throughout the world. Turkey is known to have an intermediate endemicity. The prevalence of HbsAg varies between 1.7% and 14.2%. Sixty percent of the population of Turkey is at the age of 25 and younger. The number of HBV carriers is estimated as 4 million. The aim of this study was to assess the awareness of hep¬ atitis B infection among high-school students in Adana, a city of Turkey. Materials and Methods: A survey was carried on 2352 highschool students from ten schools randomly selected in the city of Adana in 1999-2000. Data was analyzed using Statistical Package for Social Sciences (SPSS) 9.0 pocket program. ANOVA and %2 tests were used for statistical analysis. Results: Of 2352 students, 50.1% were male and 49.9% were female. Mean age was 16.5±1 years (range 14-21 years). Six questions were asked about the route of transmission of HBV: affected age groups, risk groups, the affected organ, whether it may cause cancer, and vaccination. The percentage of correct responders for these questions were 4%, 98%, 10%, 28%, 24%, and 40%, respectively. Conclusion: There was a significant relationship between aware¬ ness of hepatitis B and older age, higher grade, higher educa¬ tional status of parents, and higher family income. However, nei¬ ther the awareness nor the vaccination rates for hepatitis B among high-school students were satisfactory. Vaccination and education programmes for hepatitis B should be implemented immediately.
Bookmark/Search this post with
Abstract (Original Language): 
Amaç: Hepatit B virus (HBV) enfeksiyonu tüm dünyada karaciğer hastalıklarının önde gelen nedenidir. Türkiye orta endemisite'de bir ülke olup HbsAg prevalansı %1.7-14.2 arasında değişmektedir. Nüfusunun %60'ı 25 yaş ve altında olan ülkemizde HBV taşıyıcılarının 4 milyon kadar olduğu tahmin edilmektedir. Bu çalışmanın amacı, Adana il merkezindeki lise öğrencilerinde Hepatit B enfek¬ siyonu farkındalığını değerlendirmektir. Yöntem: Adana il merkezindeki 49 okul arasından rasgele örneklem ile seçilen 10 okulda 1999-2000 yılında öğrenim gören 2352 öğrenci çalışmaya alınmıştır. Veriler SPSS 9.0 programı ile analiz edilmiştir. istatistiksel değerlendirmede ANOVA ve ki-kare testleri kullanılmıştır. Bulgular: Örneklemdeki 2352 öğrencinin %50.1'i erkek, %49.9'u kızdı. Ortalama yaş 16.5±1 yıldı (aralık 14-21 yaş). HBV geçiş yolu, etkilediği yaş grubu, risk grupları, etkilenen organ ve kanserle ilişkisi ve aşı hakkında 6 soru soruldu. Sorulara verilen doğru cevap oranı sırasıyla; %4, %98, %10, %28, %24 ve %40 olarak sap¬ tandı. Sonuç: Hepatit B farkındalığı ile yaş, sınıf, ana-baba eğitim durumu, aile geliri arasında anlamlı ilişki olduğu saptandı. Ancak lise öğrencilerinin ne bilgi düzeyleri ne de aşılanma oranları istenen düzeyde değildi. Aşı ve eğitim programlarının acilen uygulanması gerektiği düşünülmektedir.
FULL TEXT (PDF): 
PDF icon arastrmx_116859_10_pp_25-30.pdf
  • 1
25-30
  • Turkish

REFERENCES

References: 

1. Hadler SC. Global impact of hepatitis A virus infection. Changing patterns. Ed. Hollinger FB, Lemon SM, Margolis HS. Viral Hepatitis and Liver Dise-ase'de. Baltimore, Williams & Wilkins,1991; 14-20.
2. Zuckerman JN, Zuckerman AJ. The epidemiology of hepatitis B. Clin Liver Dis 1999; 3: 179-87.
3. Vryheid RE, Kane MA, Muller N, Schatz GC, Bezabeh S. Infant and adolescent hepatitis B immunization up to 1999: a global overview. Vaccine 2000; 19: 1026-37.
4. WHO. Expanded programme on immunization. Global Advisory Group-Part I. Wkly Epidemiol Rec 1992; 67: 11-5.
5. Montalto NJ. Implementing the guidelines for adolescent preventive services. Am Family Physician 1998; 57(9): 2181-8.
6. Meheus A. Risk of hepatitis B in adolescence and young adulthood. Vaccine
1995; 13 suppl 1: 31-4.
7. Goudeau A. Epidemiology and eradication strategy for hepatitis B in Euro¬pe. The European Regional Study Group. Vaccine 1990; 8 Suppl: 113-6.
8.
Yörükoğl
u A. Gençlik. 9. baskı. İstanbul, Acar Yayınları, 1996.
9.
Kılıçturga
y K, Badur S. Viral Hepatit. 1. baskı. İstanbul, Deniz Matbaası,
2001.
10.
Güraka
r M, Gürakar A. A'dan Z'ye Hepatit. 2. baskı. İstanbul, Selçuk Ya¬yınları, 2000.
11.
Arıba
ş ET, Yılmaz A, Erayman I, Özcan M, Bitirgen M. Hepatit B virus enfeksiyonunun yatay geçişi. Viral Hepatit Dergisi 2000; 1: 33-5.
12.
Emiroğl
u H, Kesecik M, Oğuz S, Öztürk M, Nazlıgül Y, Altunay H. Şır-nak ilinde asker ve sivil popülasyonda asemptomatik hepatit B virus preva-lansı. Viral Hepatit Dergisi 2000; 1: 18-20.
13. Freed GL, Bordley WC, Clark SJ, Konrad TR. Family physician acceptance of universal hepatitis B immunization of infants. J Fam Pract 1993;
36(2): 153-7.
14. Rowan MS, Carter AO, Walker VJ. Immunization policies in Canadian medical schools. CMAJ 1994; 151(7): 957-61.
15. Osinska H. The hepatitis B prevention education programme in poland. Vac¬cine 2000;18(suppl 1): 44-5.
16. Wiecha JM. Differences in knowledge of hepatitis B among Vietnamese, Af¬rican-American, Hispanic and white adolescents in Worcester, Massachu¬setts. Paediatrics 1999; 104(5): 1212-6.
17. Khan SJ, Anjum Q, Khan NU, Nabi FG. Awareness about common diseases in selected female college students of Karachi. J Pak Med Assoc 2005;
55(5): 195-8.
18. Cheung J, Lee TK, The CZ, Wang CY, Kwan WC, Yoshida EM. Cross-
sectional study of hepatitis B awareness among Chinese and Southeast Asian Canadians in the Vancouver-Richmond community. Can J Gastroenterol
2005; 19(4): 245-9.
19. Al-Jabri AA, Al-Adawi S, Al-Abri JH, Al-Dhahry SH. Awareness of hepatitis B virus among undergraduate medical and non-medical students. Saudi Med J 2004; 25(4): 484-7.
20. Chhabra P, Grover VL, Agrawal K. Do our medical students have enough knowledge of hepatitis B? A Delhi based study. J Commun Dis 2002; 34(3):
221-5.
21. Skinner SR, Imberger A, Nolan T, Lester R, Glover S, Bowes G. Rando¬mised controlled trial of an educational strategy to increase school-based ado¬lescent hepatitis B vaccination. Aust N Z J Public Health 2000; 24(3): 298¬304.
22. Trevisan A, Borella Venturini M, Paruzzolo P, Maso S. Hepatitis B vacci¬nation awareness and biological risk. Med Lav 2002; 93(4): 318-21.
23. Wallaschofski H, Drexler H, Schmid K. Status and awareness of vaccinati¬on among medical students. Dtsch Med Wochenschr 2005; 130(23): 1429-33.
24. Lee CY, Naguel C, Gyurech D, Schilling ND. Awareness of vaccination sta¬tus and its predictors among people in Switzerland. BMC Public Health 2003;
3: 18.
25. Francois G, Hallauer J, Van Damme P. Hepatitis B vaccination: how to re¬ach risk groups. Vaccine 2002; 21(1-2): 1-4.
26. Fong NP, Basir H, Seow A. Awareness and acceptance of hepatitis B vaccina¬tion in Clementi, Singapore. Ann Acad Med Singapore 1990; 19(6): 788-92.
27. Ellsasser G. Prevention by vaccination of children and young people. Obs¬tacles and examples of effective measures in the Federal State of Branden¬burg. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2004; 47(2): 1196-203 [in German].
28. McPhee SJ, Nguven T, Euler GL, Mock J, Wong C, Lam T ve ark. Suc¬cessful promotion of hepatitis B vaccinations among Vietnamese-American children ages 3 to 18: results of a controlled trial. Pediatrics 2003; 111(6):
1278-88.
29. Hinds A, Cameron JC. Acceptability of universal hepatitis B vaccination among school pupils and parents. Commun Dis Public Health 2004; 7(4):
278-82.
30. http://www.cdc.gov/ncidod/diseases/hepatitis/resource/pubs.htm adresinden 21.6.2004 tarihinde erişilmiştir.
31. Neff MJ. CDC updates guidelines for prevention and control of infections with hepatitis viruses in correctional settings. Am Family Physician 2003;
67(12): 2620-5.
32. Mark H, Conklin VG, Wolfe MC. Nurse volunteers in school-based hepati¬tis B immunization programs. J Sch Nurs 2001; 17(4): 185-8.

Thank you for copying data from http://www.arastirmax.com